Open Access

Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN/PDCD4

  • Authors:
    • Zuopeng Wang
    • Wei Yao
    • Kai Li
    • Na Zheng
    • Chao Zheng
    • Xiaolong Zhao
    • Shan Zheng
  • View Affiliations

  • Published online on: April 20, 2017     https://doi.org/10.3892/ol.2017.6052
  • Pages: 4727-4733
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNA (miR/miRNA)-21 is a well‑known oncogenic miRNA that is overexpressed in various types of tumors. The tumor-suppressor genes programmed cell death 4 (PDCD4) and phosphatase tensin homologue (PTEN), are targets of miR‑21, and are underexpressed in several types of cancer. However, the expression of miR‑21 and its target genes in neuroblastoma (NB) remains unclear. In the present study, a miR‑21 inhibitor oligonucleotide was transfected into the SK‑N‑SH cell line, and the expression of miR‑21, PTEN and PDCD4 was detected through quantitative polymerase chain reaction analysis. Western blotting was used to examine levels of PTEN, PDCD4 and caspase‑3 proteins. The expression of PTEN and PDCD4 in the SK‑N‑SH cell line transfected with the miR‑21 inhibitor was significantly increased compared with untransfected SK‑N‑SH and negative control‑transfected cells. Cell proliferation was inhibited and the apoptotic ratio was significantly increased in miR‑21 inhibitor‑transfected cells compared with untransfected SK‑N‑SH and negative control‑transfected cells. Western blot analysis revealed a significant increase in caspase‑3 expression compared with untransfected SK‑N‑SH and negative control‑transfected cells. The results of the present study indicate that miR‑21 may serve an oncogenic role in the cellular processes underlying NB development and thus may be a novel therapeutic target for the treatment of patients with NB.
View Figures
View References

Related Articles

Journal Cover

June-2017
Volume 13 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Z, Yao W, Li K, Zheng N, Zheng C, Zhao X and Zheng S: Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN/PDCD4. Oncol Lett 13: 4727-4733, 2017
APA
Wang, Z., Yao, W., Li, K., Zheng, N., Zheng, C., Zhao, X., & Zheng, S. (2017). Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN/PDCD4. Oncology Letters, 13, 4727-4733. https://doi.org/10.3892/ol.2017.6052
MLA
Wang, Z., Yao, W., Li, K., Zheng, N., Zheng, C., Zhao, X., Zheng, S."Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN/PDCD4". Oncology Letters 13.6 (2017): 4727-4733.
Chicago
Wang, Z., Yao, W., Li, K., Zheng, N., Zheng, C., Zhao, X., Zheng, S."Reduction of miR-21 induces SK-N-SH cell apoptosis and inhibits proliferation via PTEN/PDCD4". Oncology Letters 13, no. 6 (2017): 4727-4733. https://doi.org/10.3892/ol.2017.6052